-
Spineology CEO retires
John Booth is retiring from his role as CEO and director of Spineology, a minimally invasive surgery technology company. -
The costs behind Elon Musk's Neuralink clinical trials
Thousands of prospective patients have shown interest in Neuralink, and the company overseen by Elon Musk has ambitious plans for upcoming human trials, Bloomberg reported Nov. 6. -
Stryker vs. Zimmer Biomet vs. Johnson & Johnson: How they compare in Q3 2023
Stryker, Johnson & Johnson and Zimmer Biomet posted their third quarter financial results for 2023, and data on their orthopedic sales. -
Globus Medical hits $383M in Q3 net sales
Globus Medical reported $383.6 million in global net sales during the third quarter, according to a Nov. 7 news release. -
Alphatec reports $118M in Q3 revenue
Spine medtech company Alphatec recently reported $118 million in total revenue for the third quarter of 2023. -
Orthofix launches WaveForm L interbody system
Orthofix's WaveForm L interbody sytem is out in a full commercial release, the company said Nov. 6. -
Stryker's Q3 revenue rises 9.6%: 7 notes
Stryker on Nov. 2 posted $4.9 billion in third quarter net sales. -
Centinel Spine's Prodisc revenue exceeds $17M in Q3: 8 things to know
Centinel Spine, a global medical device company and the creator of the Prodisc total disc replacement product line, has exceeded $17 million in revenue in the third quarter of the year, its highest grossing quarter to date. -
ZimVie reports $10.6M decrease in spine sales in Q3
Spine and dental devicemaker ZimVie has reported $202.9 million in third-party net sales in the third quarter of the year, down 4.9% from the third quarter of 2022. -
FloSpine earns FDA clearance for KeyLift system
FloSpine earned FDA 510(k) clearance for its KeyLift expandable interlaminar stabilization system, according to a Nov. 1 news release. -
Why 3 spine devicemakers are laying off staff in 2023
Stryker, Medtronic and DePuy Spine all announced plans to lay off employees this year. -
Xēnix Medical earns FDA clearance for sacroiliac fixation system
Xēnix Medical earned FDA clearance for its Solace sacroiliac fixation system with Nanoactiv nanotechnology, the devicemaker said Oct. 31. -
DePuy Synthes to lay off 67 Colorado employees
DePuy Spine, part of Johnson & Johnson's DePuy Synthes, is eliminating positions permanently at its Monument, Colo., facility, according to an Oct. 30 WARN letter. -
Dr. Gregory Lopez debuts ZimVie's 4.5mm Mobi-C cervical disc in US
Gregory Lopez, MD, on Oct. 30 completed the first U.S. case with ZimVie's 4.5mm Mobi-C cervical disc. -
Spine company sues Orthofix
Medtech company RSB Spine is suing medical device company Orthofix, which merged with SeaSpine, and alleging patent infringement related to four implants. -
Cutting Edge Spine earns patent for spinal fusion implant
Cutting Edge Spine earned its third U.S. patent relative to trabecular screws for all orthopedic fixation, according to an Oct. 26 news release. -
Aclarion partners with Denver hospital
Aclarion partnered with Denver-based AdventHealth Porter Hospital to add the Nociscan system for identifying chronic lower back pain, according to an Oct. 25 news release. -
ZimVie's scoliosis system surpasses 2,000 cases
ZimVie's Tether vetrebral body tethering system has been used in more than 2,000 cases, the company said Oct. 24. -
NuVasive cervical disc implant backed by 5-year study
The NuVasive Simplify cervical disc replacement implant was found to be superior to anterior cervical discectomy fusion after five years, Globus Medical said Oct. 24. -
Alphatec, Aclarion partner to commercialize spine platform
Aclarion has partnered to include its Nociscan technology within Alphatec's AlphaInformatiX for spine surgery decisionmaking, according to an Oct. 23 news release.
Page 9 of 190